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Abstract
End-stage pulmonary hypertension alters intracardiac pressures, leading to distention and failure of the right ventricle,
leftward shifting of the intraventricular septum, and, thus, underfilling of the left ventricle (LV). Following the resolution of
severely elevated pulmonary vascular resistance with bilateral lung transplantation, the LV is exposed to relatively high filling
pressures from a potentially hypertrophic right ventricle pushing blood through normalized pulmonary vascular resistance.
Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) may be a valuable tool to provide a more gradual exposure
of the LV to the newly available preload in the immediate postoperative phase of transplantation, thereby reducing the
likelihood of primary graft dysfunction developing from the LV diastolic dysfunction. This paper presents a case in which VA ECMO was initiated during cardiac arrest in a patient with advanced pulmonary hypertension and right ventricular failure
and maintained for two days for postoperative patient stability and cardiac conditioning. The discussion includes data from
transplant programs using this method to reduce the need for dual organ transplantation and postoperative primary graft
dysfunction in the allograft.

Keywords: lung transplantation, diastolic dysfunction, right ventricular failure, veno-arterial extracorporeal membrane
oxygenation, pulmonary hypertension, left ventricle remodelling

Background

Case Report

Idiopathic pulmonary artery hypertension lung transplant
patients have the highest 1-year mortality (about 25%). Still,
they also have the second-best long-term survival rate
compared to transplant recipients with other pulmonary
diseases.1 One factor contributing to this statistic is primary
graft dysfunction (PGD) caused by a small and unconditioned
left ventricle (LV) prone to developing diastolic dysfunction
when exposed to a normal or relatively high pre-load after
transplantation. These patients may benefit from veno-arterial
extracorporeal membrane oxygenation (V-A ECMO) bridging
peri-operatively to allow the LV time to condition to new
filling pressures, thereby reducing the incidence of PGD in
this population of transplant recipients.

Patient History and Presentation
The patient, in this case, is a 46-year-old female who
presents to the emergency department with four days of
worsening productive cough, shortness of breath, and
abdominal pain. She has a past medical history significant
for idiopathic pulmonary artery hypertension diagnosed in
2019, hypothyroidism, and type 2 diabetes. She complied
with her home medication regimen of dual pulmonary artery
hypertension therapy (bosentan and sildenafil) and optimized
heart failure guideline-directed medical therapy (metoprolol
succinate, spironolactone, and empagliflozin).
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In the emergency department, she developed acute
hypoxia with perioral cyanosis and cool extremities. Her
arterial blood gas showed a compensated metabolic acidosis
with a partial pressure of oxygen of 166 mm Hg and a lactate
of 6.6 mmol/L, mild transaminitis, as well as elevated brain
natriuretic peptide and troponin T levels. Her chest x-ray
revealed an enlarged cardiac silhouette and right lower lobe
consolidation.
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artery occlusive pressure of 10 mmHg, a right atrial pressure
of 21 mmHg, and a Fick cardiac index of 2.39 L/min. At this
time, the lung transplant team was consulted for evaluation,
and five days later, she arrested and required intubation, V-A
ECMO cannulation, and high-dose vasopressors. Her
transthoracic echocardiogram following this event showed
decreased LV function with an ejection fraction of 52%, and
the right ventricle was decompressed by V-A ECMO,
revealing some right ventricular hypertrophy.

Diagnosis and Intervention
Her initial transthoracic echocardiogram (Figure 1) showed
a severely enlarged right ventricle causing a small LV internal
diameter, moderate pericardial effusion without tamponade,
and abnormal septal wall motion. The parasternal short view
showed a D-sign during diastole and systole. Per the report,
there was no LV hypertrophy, and the diastolic function of the
LV was difficult to determine. Her right atrium was severely
dilated, and her tricuspid valve was reported as severely
regurgitant with a dilated inferior vena cava and mild
pulmonic valve regurgitation. Her initial right heart
catheterization measured a pulmonary artery mean pressure of
59 mm Hg, pulmonary artery occlusive pressure of 9 mm Hg,
right atrial pressure of 19 mm Hg, a Fick cardiac index of 2.17
L/min, and a pulmonary artery saturation of 55%. Following
the procedure, she was initiated on intravenous (IV)
treprostinil and dopamine with aggressive diuresis.
After titrating up to 21 ng/kg/min of IV treprostinil and 2
mcg/kg/min of dopamine, she underwent a second right heart
catheterization, which showed refractory disease with a
pulmonary artery mean pressure of 63 mmHg, pulmonary

Outcome
About a month after the arrest, she received a bilateral
lung transplant and a tricuspid valve repair. She came out of
the operating room on V-A ECMO. She required a massive
transfusion for hemorrhagic shock postoperatively, leading to
persistently elevated LV filling pressures despite diuresis. To
preserve her pulmonary artery anastomoses, her pulmonary
artery diastolic pressure was used as a surrogate for a
pulmonary artery occlusive pressure. It ranged from 10 mm
Hg immediately postoperatively to 30 mm Hg after her
transfusions. She developed grade 3 PGD, which slowly
resolved with aggressive diuresis and intermittent,
pharmacologic afterload reduction. Two days following her
transplant, she was transitioned from V-A to veno-venous (VV) ECMO with only minimal vasopressor support. After
changing cannulation from V-A to V-V, her transthoracic
echocardiogram (Figure 2) reported a hyperdynamic LV with
an ejection fraction of 79%, indeterminate LV diastolic
function, and an enlarged, hypertrophic right ventricle which
was no longer compressing the LV.

Figure 1. Pre-transplant transthoracic echocardiogram. Pre-transplant parasternal long axis and short axis views show a
distended right ventricle and D-sign. Reported values: left ventricle ejection fraction 73%, left ventricle internal diameter
during diastole 2.74 cm.
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Figure 2. Post-transplant transthoracic echocardiogram. Post-transplant parasternal long axis and short axis views show a
decompressed right ventricle and larger left ventricle internal diameter. Reported values: left ventricle ejection fraction 79%,
left ventricle internal diameter during diastole 3.11 cm.

Comment
The concept of right ventricular failure in the setting of
pulmonary artery hypertension contributing to an
unconditioned LV is not new.2-3 However, treatment
approaches to this problem vary from peri-operative V-A
ECMO to inotropes with aggressive diuresis. Primary
pulmonary artery hypertension comprises 5-6% of lung
transplantation nationally, and postoperative ECMO data is
not tracked.1 However, in the center where this case occurred,
postoperative ECMO is rarely utilized in pulmonary
hypertension lung transplant cases. This patient was
particularly vulnerable to PGD because of her peri-operative
mechanical ventilation and the large volume of blood
administration due to coagulopathies related to IV
prostacyclin analogue administration. She remained on V-A
ECMO postoperatively, with the understanding that she was
at high risk for developing PGD and requiring cardiac support
in the immediate postoperative period that may not have been
adequately supported with IV inotropes alone.
In 2002, a team in Austria published a prospective study
(n=17) in which they found that peri-operative V-A ECMO,
instead of cardiopulmonary bypass, reduces postoperative
reperfusion injury by reducing forceful blood flow through the
graft initially.4 Their study resulted in more controlled
reperfusion, less aggressive ventilation strategies, and
improved postoperative hemodynamics.4 Another prospective
study of 23 bilateral lung transplants for patients with severe
pulmonary hypertension in Germany looked at V-A ECMO as
a bridge for LV conditioning while monitoring left atrial
pressures, invasive hemodynamics, and LV diameter for
weaning.5 They reported decreased total ventilator, intensive

care unit, and inpatient days with increased 90-day and 1-year
survival rates (94%) in their transplant-ECMO group as
compared to their other groups.5
The physiology of a poorly conditioned LV also exists
among the chronic thromboembolic pulmonary hypertension
population, as evidenced by a study conducted in the
Netherlands, which revealed a reversible reduction in LV free
wall mass likely related to atrophic remodeling in the setting
of right ventricular failure among patients with chronic
thromboembolic pulmonary hypertension (CTEPH).6 Though
the application of V-A ECMO is not without risk of
complications, this is an exciting topic and deserves the focus
of future research because of its potential to reduce the need
for dual heart-lung transplantation and improve the one-year
survival of pulmonary hypertension patients undergoing
transplantation. The concept also may have application among
CTEPH
patients
undergoing
pulmonary
thromboendarterectomy.
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